Latest Breaking News On - Identifies organ specific - Page 1 : comparemela.com

Positive New Data from Phase 1/2 Trial of AT-01 (Iodine

AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific.

British columbiaSan franciscoUnited statesEmily martinLuke heagleAttralus incUniversity of tennessee research foundationSociety of nuclear medicine molecular imagingUniversity of tennessee graduate school medicineCancer theranostics programTennessee graduate schoolNuclear medicineMolecular imagingAnnual meetingImaging resultsOral presentation

Attralus to Present New AT-01 Data at 2022 Society of

Final Phase 1/2 Study Results for AT-01 (Evuzamitide), Attralus's Novel Pan-Amyloid Imaging Agent for the Detection of Systemic Amyloidosis Repeat PET/CT.

British columbiaSan franciscoUnited statesEmily martinLuke heagleGregory bellAttralus incUniversity of tennessee research foundationSociety of nuclear medicine molecular imagingUniversity of tennessee graduate school medicineCancer theranostics programFinal phaseNovel pan amyloid imaging agentSystemic amyloidosisIdentifies organ specificTennessee graduate school

Attralus to Present New AT-01 Data at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting

Attralus to Present New AT-01 Data at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

British columbiaSan franciscoUnited statesEmily martinLuke heagleGregory bellAttralus incUniversity of tennessee research foundationSociety of nuclear medicine molecular imagingUniversity of tennessee graduate school medicineCancer theranostics programFinal phaseNovel pan amyloid imaging agentSystemic amyloidosisIdentifies organ specificTennessee graduate school

Attralus to Present New AT-01 Data at 2022 Society of

Final Phase 1/2 Study Results for AT-01 (Evuzamitide), Attralus's Novel Pan-Amyloid Imaging Agent for the Detection of Systemic Amyloidosis Repeat PET/CT.

British columbiaSan franciscoUnited statesEmily martinLuke heagleGregory bellAttralus incUniversity of tennessee research foundationSociety of nuclear medicine molecular imagingUniversity of tennessee graduate school medicineCancer theranostics programFinal phaseNovel pan amyloid imaging agentSystemic amyloidosisIdentifies organ specificTennessee graduate school